Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer

NCT00185588 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Vatalanib
DRUG: Gemcitabine

Sponsor

George Albert Fisher

Collaborators

[object Object]